granted
on 16 Jan 2024
Last Applicant/ Owned by
1020 First Avenue
King of Prussia
PA
19406
Serial Number
97476574 filed on 27th Jun 2022
Registration Number
N/A
Correspondent Address
Scott D. Woldow
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"ESKD"
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials "ESKD" Providing medical information and treatment of diseases and disorders of the blood and blood-forming organs, cardiovascular diseases and disorders, renal diseases and disorders information in the field of health, pharmaceuticals and clinical trials The English translation of "POSIBILRead More
Providing medical information and treatment of diseases and disorders of the blood and blood-forming organs, cardiovascular diseases and disorders, renal diseases and disorders information in the field of health, pharmaceuticals and clinical trials
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Educational services, namely, presentations and manuals in the field of health and treatment; Publication of books, journals, periodicals, magazine articles, other printed matter of the results of clinical trials
No 97476574
No Service Mark
No 034845.344
No
No
No
No
No
No
No
No
The mark consists of the stylized wording "POSIBIL", a subscript 6 to the bottom right corner of the wording "POSIBIL" and the stylized wording "ESKD" to the right.
| Status Date | Action Taken |
|---|---|
| 18th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
| 16th Jan 2024 | SOU EXTENSION 1 FILED |
| 16th Jan 2024 | SOU EXTENSION 1 GRANTED |
| 15th Aug 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 20th Jun 2023 | PUBLISHED FOR OPPOSITION |
| 20th Jun 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 31st May 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 15th May 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 20th Apr 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
